About Us

We are a high-tech company that engaged in the management of pharmaceutical and chemical raw materials and the development, production and operation of pharmaceutical raw materials.

Changzhou Yuanda Pharmaceutical Chemical Co., Ltd. is a high tech enterprise specialized in the operation of pharmaceutical chemical materials and the research of pharmaceutical bulk material.

Over the past decades, we have summed up a set of relatively complete technological innovation and development system. Our company concentrates on the production of high difficulty medicines, especially cardio-cerebral-vascular medicine, anti-cancer drugs, senile dementia prevention drugs etc. Until now, we have successfully developed more than 40 kinds of high grade bulk drugs and important intermediates, such as Ticagrelor, Rivaroxaban, Dabigatran etexilate mesylate, Rosuvastatin, Pitavastatin Calcium, Atorvastatin Calcium, Ezetimibe, Pregabalin, Doxycycline, LCZ696, Canagliflozin, Obeticholic Acid, Tofacitinib, Folic acid, Sofosbuvir, Ledipasvir, Velpatasvir, Boceprevir, Venetoclax, Niraparib, Sugammadex sodium, Delafloxacin, Riociguat, Olopatadine, Roflumilas etc. Meanwhile, we also provide complete set of services including synthetic technique, analysis test, patent business, register regulation and etc.

Over the years, our company attended all important pharmaceutical exhibitions, such as CPHI Shanghai, CPHI Japan, CPHI Korea, CPHI Germany, CPHI Russia, CPHI Turkey and CPHI worldwide. Through the exhibition, We built up deep partnerships with many new and old customers that from different countries.

Sincerely welcome your visit and look forward to build long term cooperation with you !

    Home   |   About Us   |   News   |   Products   |   R & D   |   Jobs   |   Contact Us   |   中文版

    Copyright(C)2018, Changzhou Yuanda Pharmaceutical Chemical Co., Ltd.  All Rights Reserved. Supported by ChinaChemNet ChemNet Toocle Copyright Notice 备案序号:苏ICP备13022639号

 
点击这里给我发消息
朱经理
点击这里给我发消息
袁经理
点击这里给我发消息
是经理
点击这里给我发消息
李经理
点击这里给我发消息
黄经理